What Is Male Factor Infertility?

Male factor infertility refers to a man’s inability to contribute to conception due to issues with sperm production, function, or delivery. It accounts for approximately 40–50% of all infertility cases, either alone or alongside female causes (male infertility). While often underdiagnosed, male infertility is just as likely as female infertility to be a barrier to pregnancy.

Prevalence and Global Burden

According to the World Health Organization, about 1 in 6 couples globally face infertility at some point, and male factor is involved in nearly half the cases (infertility fact sheet). In the United States, CDC data shows that roughly 12% of men aged 25–44 have experienced fertility challenges with a partner (male fertility prevalence).

Despite its prevalence, male infertility often remains a less-discussed topic, leading to delayed diagnosis and treatment. Public awareness campaigns and accessible testing options are helping normalize male fertility evaluations as part of standard reproductive care.

Causes and Risk Factors

Common causes of male infertility include:

• Low sperm count or poor motility

• Hormonal imbalances in the hypothalamic-pituitary-gonadal axis

• Obstruction in sperm transport, such as ejaculatory duct blockage

• Genetic infertility disorders, like Y chromosome deletions and Klinefelter syndrome (genetics of infertility)

• Environmental and lifestyle factors, including alcohol, smoking, and obesity

• Age-related sperm issues, including DNA fragmentation and decreased motility (causes of male infertility)

Other potential contributors include prolonged heat exposure (e.g., hot tubs), medications like testosterone replacement therapy, or previous infections such as mumps orchitis. In many cases, more than one factor may be present.

Diagnosis and Evaluation

A thorough assessment typically includes:

• Semen analysis to check concentration, shape, and movement

• Hormone testing for FSH, LH, and testosterone

• Scrotal ultrasound for detecting varicocele or testicular damage

• Genetic screening if azoospermia or very low sperm counts are present

• Testicular biopsy when non-obstructive causes are suspected (male infertility evaluation)

The CDC ART glossary defines male factor infertility as any condition where abnormal semen parameters impair the chances of successful fertilization (male factor definition in ART).

Additional tests, such as sperm DNA fragmentation or reactive oxygen species (ROS) assessments, may be used in complex or unexplained cases, particularly when standard parameters appear normal but infertility persists.

Treatment Options

Depending on the cause, treatment may involve:

• Lifestyle changes to reduce risk factors

• Hormonal therapies for endocrine disorders

• Surgical procedures like varicocelectomy or vasovasostomy

• Assisted reproductive technologies such as IVF and ICSI

• Sperm retrieval methods in men with no sperm in ejaculate

In cases of severe male factor infertility, intracytoplasmic sperm injection (ICSI)—a technique where a single sperm is injected directly into an egg—has dramatically improved success rates. Men with genetic conditions may also consider preimplantation genetic testing (PGT) as part of treatment.

Research into emerging male fertility treatments, including antioxidants and epigenetic therapies, is ongoing (trends in male factor infertility).

Prognosis

Outcomes vary, but many men achieve pregnancy through timely intervention and assisted techniques. Mild-to-moderate male infertility can often be managed effectively with lifestyle and medical therapies. Severe cases may still achieve success through ART.

Early testing, targeted treatment, and ongoing monitoring are key to managing male infertility effectively and ensuring couples have access to comprehensive reproductive care.